1. Home
  2. BLRX vs GYRO Comparison

BLRX vs GYRO Comparison

Compare BLRX & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • GYRO
  • Stock Information
  • Founded
  • BLRX 2003
  • GYRO 1946
  • Country
  • BLRX Israel
  • GYRO United States
  • Employees
  • BLRX N/A
  • GYRO N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • BLRX Health Care
  • GYRO Real Estate
  • Exchange
  • BLRX Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • BLRX 17.3M
  • GYRO 19.8M
  • IPO Year
  • BLRX 2011
  • GYRO N/A
  • Fundamental
  • Price
  • BLRX $0.10
  • GYRO $9.22
  • Analyst Decision
  • BLRX Strong Buy
  • GYRO
  • Analyst Count
  • BLRX 2
  • GYRO 0
  • Target Price
  • BLRX $5.50
  • GYRO N/A
  • AVG Volume (30 Days)
  • BLRX 18.8M
  • GYRO 467.0
  • Earning Date
  • BLRX 11-25-2024
  • GYRO 01-01-0001
  • Dividend Yield
  • BLRX N/A
  • GYRO N/A
  • EPS Growth
  • BLRX N/A
  • GYRO N/A
  • EPS
  • BLRX N/A
  • GYRO N/A
  • Revenue
  • BLRX $21,991,000.00
  • GYRO $2,738,019.00
  • Revenue This Year
  • BLRX N/A
  • GYRO N/A
  • Revenue Next Year
  • BLRX N/A
  • GYRO N/A
  • P/E Ratio
  • BLRX N/A
  • GYRO N/A
  • Revenue Growth
  • BLRX N/A
  • GYRO N/A
  • 52 Week Low
  • BLRX $0.08
  • GYRO $7.65
  • 52 Week High
  • BLRX $1.44
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 28.83
  • GYRO 49.42
  • Support Level
  • BLRX $0.23
  • GYRO $9.02
  • Resistance Level
  • BLRX $0.14
  • GYRO $9.88
  • Average True Range (ATR)
  • BLRX 0.03
  • GYRO 0.01
  • MACD
  • BLRX -0.00
  • GYRO 0.01
  • Stochastic Oscillator
  • BLRX 6.93
  • GYRO 52.63

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: